Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|August 29, 1992
Adjuvant radiotherapy and risk of contralateral breast cancerH H Storm, M Andersson, J D Boice, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1989
Significance of incisional biopsy in breast carcinoma: results from a clinical trial with intended excisional biopsyS Watt-Boolsen, G Ottesen, J A Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B TrialM Andersson, C Kamby, M B Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-BP Dombernowsky, H Brincker, M Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancerJ Pedersen-Bjergaard, T C Sigsgaard, D Nielsen, et al.
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Cancer Treatment Reports|January 1, 1983
Role of radiation therapy in small cell anaplastic carcinoma of the lungN M Bleehen, P A Bunn, J D Cox, et al.
Breast Cancer Research and Treatment|January 1, 1986
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisoneC Rose, C Kamby, H T Mouridsen, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|August 29, 1992
Adjuvant radiotherapy and risk of contralateral breast cancerH H Storm, M Andersson, J D Boice, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1989
Significance of incisional biopsy in breast carcinoma: results from a clinical trial with intended excisional biopsyS Watt-Boolsen, G Ottesen, J A Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B TrialM Andersson, C Kamby, M B Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-BP Dombernowsky, H Brincker, M Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancerJ Pedersen-Bjergaard, T C Sigsgaard, D Nielsen, et al.
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Cancer Treatment Reports|January 1, 1983
Role of radiation therapy in small cell anaplastic carcinoma of the lungN M Bleehen, P A Bunn, J D Cox, et al.
Breast Cancer Research and Treatment|January 1, 1986
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisoneC Rose, C Kamby, H T Mouridsen, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Classical prognostic factors in node-negative breast cancer: the DBCG experienceH T Mouridsen, J Andersen, K W Andersen, et al.
Pageof 22